These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 10150182

  • 1. Effects of defibrotide on physical performance and hemorheologic picture in patients with peripheral arteriopathy.
    Marrapodi E, Leanza D, Giordano S, Nazzari M, Corsi C.
    Clin Trials Metaanal; 1994 Apr; 29(1):21-30. PubMed ID: 10150182
    [Abstract] [Full Text] [Related]

  • 2. A double-blind, multicenter, placebo-controlled, dose comparison study of orally administered defibrotide: preliminary results in patients with peripheral arterial disease.
    Strano A, Fareed J, Sabbá C, Albano O, Allegra C, Carlizza A, Binaghi F, Fronteddu F, Del Guercio R, Arpaia MR.
    Semin Thromb Hemost; 1991 Apr; 17 Suppl 2():228-34. PubMed ID: 1948094
    [Abstract] [Full Text] [Related]

  • 3. [Clinical experience in patients with chronic peripheral obliterating arteriopathy: defibrotide versus definite molecular weight heparan sulfate (MW 7500-15000 dalton)].
    Michelini S, Micci A, Failla A, Grechi G, Iantaffi A.
    Minerva Cardioangiol; 1996 Apr; 44(1-2):33-7. PubMed ID: 8767620
    [Abstract] [Full Text] [Related]

  • 4. A pilot evaluation of the effect of defibrotide in patients affected by peripheral arterial occlusive disease.
    Sabbá C, Zupo V, Dina F, Nazzari M, Albano O.
    Int J Clin Pharmacol Ther Toxicol; 1988 May; 26(5):249-52. PubMed ID: 3045026
    [Abstract] [Full Text] [Related]

  • 5. Improvement of walking distance by defibrotide in patients with intermittent claudication--results of a randomized, placebo-controlled study (the DICLIS study). Defibrotide Intermittent CLaudication Italian Study.
    Violi F, Marubini E, Coccheri S, Nenci GG.
    Thromb Haemost; 2000 May; 83(5):672-7. PubMed ID: 10823260
    [Abstract] [Full Text] [Related]

  • 6. Effects of defibrotide after oral and parenteral administration in patients with peripheral obliterative arterial disease (POAD).
    Craveri A, Tornaghi G, Ranieri R, Stanzani M, Landi G, Paganardi L, Passaretti B, Gallo E.
    Int Angiol; 1990 May; 9(4):274-7. PubMed ID: 2099963
    [Abstract] [Full Text] [Related]

  • 7. Effects of oral and intravenous defibrotide on blood viscosity in patients with peripheral obliterative arterial disease.
    Belfiglio A, Traietti P, Bologna E, Salvo G.
    Clin Ther; 1989 May; 11(4):479-84. PubMed ID: 2776165
    [Abstract] [Full Text] [Related]

  • 8. Treatment of intermittent claudication with defibrotide or mesoglycan. A double blind study.
    Laurora G, Ambrosoli L, Cesarone MR, De Sanctis MT, Incandela L, Marelli C, Belcaro G.
    Panminerva Med; 1994 Jun; 36(2):83-6. PubMed ID: 7831064
    [Abstract] [Full Text] [Related]

  • 9. Effect of glutathione infusion on leg arterial circulation, cutaneous microcirculation, and pain-free walking distance in patients with peripheral obstructive arterial disease: a randomized, double-blind, placebo-controlled trial.
    Arosio E, De Marchi S, Zannoni M, Prior M, Lechi A.
    Mayo Clin Proc; 2002 Aug; 77(8):754-9. PubMed ID: 12173710
    [Abstract] [Full Text] [Related]

  • 10. Defibrotide and peripheral obliterative arterial disease: preliminary data.
    Arosio E, Pancera P, Zannoni M, Arcaro G, Priante F, Lechi A.
    Int J Clin Pharmacol Ther Toxicol; 1989 Nov; 27(11):526-9. PubMed ID: 2533180
    [Abstract] [Full Text] [Related]

  • 11. The influence of iloprost on blood rheology and tissue perfusion in patients with intermittent claudication.
    Ciuffetti G, Sokola E, Lombardini R, Pasqualini L, Pirro M, Mannarino E.
    Kardiol Pol; 2003 Sep; 59(9):197-204. PubMed ID: 14618196
    [Abstract] [Full Text] [Related]

  • 12. Treatment of intermittent claudication with mesoglycan--a placebo-controlled, double-blind study.
    Nenci GG, Gresele P, Ferrari G, Santoro L, Gianese F, Mesoglycan Intermittent Claudication Group.
    Thromb Haemost; 2001 Nov; 86(5):1181-7. PubMed ID: 11816704
    [Abstract] [Full Text] [Related]

  • 13. Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication.
    Dawson DL, Zheng Q, Worthy SA, Charles B, Bradley DV.
    Angiology; 2002 Nov; 53(5):509-20. PubMed ID: 12365857
    [Abstract] [Full Text] [Related]

  • 14. Hemodynamic, hemorheologic, and hemocoagulative changes after treatment with picotamide in patients affected by peripheral arterial disease (PAD) of the lower limbs.
    Neirotti M, Molaschi M, Ponzetto M, Macchione C, Poli L, Bonino F, Fabris F.
    Angiology; 1994 Feb; 45(2):137-41. PubMed ID: 8129189
    [Abstract] [Full Text] [Related]

  • 15. A randomized trial of iloprost in patients with intermittent claudication.
    Creager MA, Pande RL, Hiatt WR.
    Vasc Med; 2008 Feb; 13(1):5-13. PubMed ID: 18372433
    [Abstract] [Full Text] [Related]

  • 16. Improving walking ability and ankle brachial pressure indices in symptomatic peripheral vascular disease with intermittent pneumatic foot compression: a prospective controlled study with one-year follow-up.
    Delis KT, Nicolaides AN, Wolfe JH, Stansby G.
    J Vasc Surg; 2000 Apr; 31(4):650-61. PubMed ID: 10753272
    [Abstract] [Full Text] [Related]

  • 17. Anti-chlamydial antibiotic therapy for symptom improvement in peripheral artery disease: prospective evaluation of rifalazil effect on vascular symptoms of intermittent claudication and other endpoints in Chlamydia pneumoniae seropositive patients (PROVIDENCE-1).
    Jaff MR, Dale RA, Creager MA, Lipicky RJ, Constant J, Campbell LA, Hiatt WR.
    Circulation; 2009 Jan 27; 119(3):452-8. PubMed ID: 19139383
    [Abstract] [Full Text] [Related]

  • 18. Rapid foot and calf compression increases walking distance in patients with intermittent claudication: results of a randomized study.
    Ramaswami G, D'Ayala M, Hollier LH, Deutsch R, McElhinney AJ.
    J Vasc Surg; 2005 May 27; 41(5):794-801. PubMed ID: 15886663
    [Abstract] [Full Text] [Related]

  • 19. PoleStriding exercise and vitamin E for management of peripheral vascular disease.
    Collins EG, Edwin Langbein W, Orebaugh C, Bammert C, Hanson K, Reda D, Edwards LC, Littooy FN.
    Med Sci Sports Exerc; 2003 Mar 27; 35(3):384-93. PubMed ID: 12618567
    [Abstract] [Full Text] [Related]

  • 20. [Effect of calciparine in the mid-term treatment of peripheral arteriopathy of the lower extremities].
    Stanzani M, Colombo L, Altomare S, Pagnozzi G, Barbieri C, Bruschi R, Pietrasanta E.
    Minerva Cardioangiol; 1993 Oct 27; 41(10):465-8. PubMed ID: 8302443
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.